The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models (2016)
Attributed to:
Is targeting vascular remodelling by filarial parasites a viable anti-morbidity solution?
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13071-016-1381-0
PubMed Identifier: 26897363
Publication URI: http://europepmc.org/abstract/MED/26897363
Type: Journal Article/Review
Parent Publication: Parasites & Vectors
Issue: 1
ISSN: 1756-3305